Galangin attenuates mast cell-mediated allergic inflammation

Food and Chemical Toxicology

Volumn 57, Issue , 2013, Pages 209-216

  Kim, Hui Hun ^a,b   Bae, Yunju ^a   Kim, Sang Hyun ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Korean Promotion Institute for Traditional Medicine Industry   (South Korea)

Author keywords

Allergic inflammation; Galangin; Histamine; Inflammatory cytokine; Mast cells

Indexed keywords

CALCIMYCIN; CROMOGLYCATE DISODIUM; GALANGIN; HISTAMINE RECEPTOR; HISTAMINE RECEPTOR 1; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; INTERLEUKIN 8; PHORBOL 13 ACETATE 12 MYRISTATE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MAST CELL; MOUSE; NONHUMAN; PASSIVE SKIN ANAPHYLAXIS; PROTEIN EXPRESSION;

ANAPHYLAXIS; ANIMALS; ANTI-ALLERGIC AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALCIUM; CASPASE 1; CELLS, CULTURED; CYTOKINES; FLAVONOIDS; HISTAMINE RELEASE; HUMANS; HYPERSENSITIVITY; INFLAMMATION; MALE; MAST CELLS; MICE, INBRED ICR; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 84876697117     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.03.015     Document Type: Article

References (50)

1. Amin K. The role of mast cells in allergic inflammation. Respir. Med. 2012, 106:9-14.
2. Azzolina A., Bongiovanni A., Lampiasi N. Substance P induces TNF-alpha and IL-6 production through NF kappa B in peritoneal mast cells. Biochim. Biophys. Acta 2003, 1643:75-83.
3. Bae Y., Lee S., Kim S.H. Chrysin suppresses mast cell-mediated allergic inflammation: involvement of calcium, caspase-1 and nuclear factor-kappaB. Toxicol. Appl. Pharmacol. 2011, 254:56-64.
4. Bestwick C.S., Milne L. Influence of galangin on HL-60 cell proliferation and survival. Cancer Lett. 2006, 243:80-89.
5. Castellani M.L., De Lutiis M.A., Toniato E., Conti F., Felaco P., Fulcheri M., Theoharides T.C., Caraffa A., Antinolfi P., Conti P., Cuccurullo C., Ciampoli C., Felaco M., Orso C., Salini V., Cerulli G., Kempuraj D., Tete S., Shaik B. Impact of RANTES, MCP-1 and IL-8 in mast cells. J. Biol. Reg. Homeos. Ag. 2010, 24:1-6.
6. Cushnie T.P., Hamilton V.E., Chapman D.G., Taylor P.W., Lamb A.J. Aggregation of Staphylococcus aureus following treatment with the antibacterial flavonol galangin. J. Appl. Microbiol. 2007, 103:1562-1567.
7. Dambros M., van Deutekom M., de Jongh R., van Koeveringe G.A., De Mey J.G., van Kerrebroeck P. The inhibitory effect of the flavonoid galangin on urinary bladder smooth muscle contractility is mediated in part by modulation of Ca2+ release from intracellular stores. Planta Med. 2005, 71:962-964.
8. DiDonato J.A., Mercurio F., Karin M. NF-kappaB and the link between inflammation and cancer. Immunol. Rev. 2012, 246:379-400.
9. Eisenhut M., Wallace H. Ion channels in inflammation. Pflugers Arch. 2011, 461:401-421.
10. Galli S.J., Tsai M., Piliponsky A.M. The development of allergic inflammation. Nature 2008, 454:445-454.
11. Gomez G., Gonzalez-Espinosa C., Odom S., Baez G., Cid M.E., Ryan J.J., Rivera J. Impaired FcepsilonRI-dependent gene expression and defective eicosanoid and cytokine production as a consequence of Fyn deficiency in mast cells. J. Immunol. 2005, 175:7602-7610.
12. Grimbaldeston M.A., Metz M., Yu M., Tsai M., Galli S.J. Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses. Curr. Opin. Immunol. 2006, 18:751-760.
13. Huh J.E., Jung I.T., Choi J., Baek Y.H., Lee J.D., Park D.S., Choi D.Y. The natural flavonoid galangin inhibits osteoclastic bone destruction and osteoclastogenesis by suppressing NF-kappaB in collagen-induced arthritis and bone marrow-derived macrophages. Eur. J. Pharmacol. 2012.
14. Jutel M., Watanabe T., Akdis M., Blaser K., Akdis C.A. Immune regulation by histamine. Curr. Opin. Immunol. 2002, 14:735-740.
15. Jutel M., Akdis M., Akdis C.A. Histamine, histamine receptors and their role in immune pathology. Clin. Exp. Allergy 2009, 39:1786-1800.
16. Kim S.H., Jun C.D., Suk K., Choi B.J., Lim H., Park S., Lee S.H., Shin H.Y., Kim D.K., Shin T.Y. Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells. Toxicol. Sci. 2006, 91:123-131.
17. Kim H.H., Yoo J.S., Lee H.S., Kwon T.K., Shin T.Y., Kim S.H. Elsholtzia ciliata inhibits mast cell-mediated allergic inflammation: role of calcium, p38 mitogen-activated protein kinase and nuclear factor-{kappa}B. Exp. Biol. Med. (Maywood) 2011, 236:1070-1077.
18. Ku G., Faust T., Lauffer L.L., Livingston D.J., Harding M.W. Interleukin-1 beta converting enzyme inhibition blocks progression of type II collagen-induced arthritis in mice. Cytokine 1996, 8:377-386.
19. Lamkanfi M., Walle L.V., Kanneganti T.D. Deregulated inflammasome signaling in disease. Immunol. Rev. 2011, 243:163-173.
20. Lattig J., Bohl M., Fischer P., Tischer S., Tietbohl C., Menschikowski M., Gutzeit H.O., Metz P., Pisabarro M.T. Mechanism of inhibition of human secretory phospholipase A2 by flavonoids: rationale for lead design. J. Comput. Aid. Mol. Des. 2007, 21:473-483.
21. Law M., Morales J.L., Mottram L.F., Iyer A., Peterson B.R., August A. Structural requirements for the inhibition of calcium mobilization and mast cell activation by the pyrazole derivative BTP2. Int. J. Biochem. Cell Biol. 2011, 43:1228-1239.
22. Lee S., Yun H.S., Kim S.H. The comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosis. Biomaterials 2011, 32:9434-9443.
23. Lin T.J., Garduno R., Boudreau R.T., Issekutz A.C. Pseudomonas aeruginosa activates human mast cells to induce neutrophil transendothelial migration via mast cell-derived IL-1 alpha and beta. J. Immunol. 2002, 169:4522-4530.
24. Ma H.T., Beaven M.A. Regulators of Ca(2+) signaling in mast cells: potential targets for treatment of mast cell-related diseases?. Adv. Exp. Med. Biol. 2011, 716:62-90.
25. Manikandan J., Kothandaraman N., Hande M.P., Pushparaj P.N. Deciphering the structure and function of FcepsilonRI/mast cell axis in the regulation of allergy and anaphylaxis: a functional genomics paradigm. Cell Mol. Life Sci. 2012, 69:1917-1929.
26. Mican J.A., Arora N., Burd P.R., Metcalfe D.D. Passive cutaneous anaphylaxis in mouse skin is associated with local accumulation of interleukin-6 mRNA and immunoreactive interleukin-6 protein. J. Allergy Clin. Immunol. 1992, 90:815-824.
27. Morello S., Vellecco V., Alfieri A., Mascolo N., Cicala C. Vasorelaxant effect of the flavonoid galangin on isolated rat thoracic aorta. Life Sci. 2006, 78:825-830.
28. Murray T.J., Yang X., Sherr D.H. Growth of a human mammary tumor cell line is blocked by galangin, a naturally occurring bioflavonoid, and is accompanied by down-regulation of cyclins D3, E, and A. Breast Cancer Res. 2006, 8:R17.
29. Nakagomi D., Suzuki K., Nakajima H. Critical roles of IkB kinase subunits in mast cell degranulation. Int. Arch. Allergy Immunol. 2012, 158(Suppl. 1):92-95.
30. Nakamura R., Watanabe K., Oka K., Ohta S., Mishima S., Teshima R. Effects of propolis from different areas on mast cell degranulation and identification of the effective components in propolis. Int. Immunopharmacol. 2010, 10:1107-1112.
31. Newton, K., Dixit, V.M., 2012. Signaling in innate immunity and inflammation. Cold Spring Harb Perspect, Biol 4.
32. O'Mahony L., Akdis M., Akdis C.A. Regulation of the immune response and inflammation by histamine and histamine receptors. J. Allergy Clin. Immunol. 2011, 128:1153-1162.
33. Pasparakis M. Role of NF-kappaB in epithelial biology. Immunol. Rev. 2012, 246:346-358.
34. Rivera J., Fierro N.A., Olivera A., Suzuki R. New insights on mast cell activation via the high affinity receptor for IgE. Adv. Immunol. 2008, 98:85-120.
35. Russo A., Longo R., Vanella A. Antioxidant activity of propolis: role of caffeic acid phenethyl ester and galangin. Fitoterapia 2002, 73(Suppl. 1):S21-S29.
36. Sarchio S.N., Kok L.F., O'Sullivan C., Halliday G.M., Byrne S.N. Dermal mast cells affect the development of sunlight-induced skin tumours. Exp. Dermatol. 2012, 21:241-248.
37. Scheller J., Chalaris A., Schmidt-Arras D., Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim. Biophys. Acta 2011, 1813:878-888.
38. Schnitzler P., Neuner A., Nolkemper S., Zundel C., Nowack H., Sensch K.H., Reichling J. Antiviral activity and mode of action of propolis extracts and selected compounds. Phytother. Res. 2010, 24(Suppl. 1):S20-S28.
39. Simons F.E., Simons K.J. Histamine and H1-antihistamines: celebrating a century of progress. J. Allergy Clin. Immunol. 2011, 128(1139-1150):e1134.
40. Singh T.S., Lee S., Kim H.H., Choi J.K., Kim S.H. Perfluorooctanoic acid induces mast cell-mediated allergic inflammation by the release of histamine and inflammatory mediators. Toxicol. Lett. 2012, 210:64-70.
41. Sivakumar A.S., Anuradha C.V. Effect of galangin supplementation on oxidative damage and inflammatory changes in fructose-fed rat liver. Chem. Biol. Interact. 2011, 193:141-148.
42. Stack J.H., Beaumont K., Larsen P.D., Straley K.S., Henkel G.W., Randle J.C., Hoffman H.M. IL-converting enzyme/caspase-1 inhibitor VX-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from familial cold autoinflammatory syndrome patients. J. Immunol. 2005, 175:2630-2634.
43. Strowig T., Henao-Mejia J., Elinav E., Flavell R. Inflammasomes in health and disease. Nature 2012, 481:278-286.
44. Tanaka S., Mikura S., Hashimoto E., Sugimoto Y., Ichikawa A. Ca2+ influx-mediated histamine synthesis and IL-6 release in mast cells activated by monomeric IgE. Eur. J. Immunol. 2005, 35:460-468.
45. Tolomeo M., Grimaudo S., Di Cristina A., Pipitone R.M., Dusonchet L., Meli M., Crosta L., Gebbia N., Invidiata F.P., Titone L., Simoni D. Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cells. Cancer Lett. 2008, 265:289-297.
46. Turner M.D., Chaudhry A., Nedjai B. Tumour necrosis factor receptor trafficking dysfunction opens the TRAPS door to pro-inflammatory cytokine secretion. Biosci. Rep. 2012, 32:105-112.
47. Vandenabeele, P., Declercq, W., Van Herreweghe, F., Vanden Berghe, T., 2010. The role of the kinases RIP1 and RIP3 in TNF-induced necrosis. Sci. Signal 3, re4.
48. Walczak H. TNF and ubiquitin at the crossroads of gene activation, cell death, inflammation, and cancer. Immunol. Rev. 2011, 244:9-28.
49. Wang X., Liu Y. Regulation of innate immune response by MAP kinase phosphatase-1. Cell. Signal. 2007, 19:1372-1382.
50. Zucchi R., Chiellini G., Scanlan T.S., Grandy D.K. Trace amine-associated receptors and their ligands. Brit. J. Pharmacol. 2006, 149:967-978.